Baricitinib-d5
Baricitinib-d5 is the deuterium labeled Baricitinib. Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.
Product Specifications
Product Name Alternative
LY3009104-d5; INCB028050-d5
UNSPSC
12352005
Target
JAK
Type
Isotope-Labeled Compounds
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Inflammation/Immunology
Purity
98.98
Solubility
10 mM in DMSO
Smiles
N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(S(=O)(C([2H])([2H])C([2H])([2H])[2H])=O)C1
Molecular Formula
C16H12D5N7O2S
Molecular Weight
376.45
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Fridman JS, et al. Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050. J Immunol. 2010 May 1;184 (9) :5298-307.|[3]Jabbari A, et al. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib. EBioMedicine. 2015 Feb 26;2 (4) :351-5.|[4]Khan IM, et al. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration resistance. Int J Obes (Lond) . 2015 Nov;39 (11) :1607-18.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-15315S/Baricitinib-d5-SDS-MedChemExpress.pdf
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
CAS Number
[1564241-79-7]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![(2E) -3-[3- (1-Adamantyl) -1-phenyl-1H-pyrazol-4-yl]-acrylic acid](https://cdn.genprice.uk/genprice/genprice4.png)
GTR15283081 1 Vial
Lentiviral mouse Ccl17 shRNA (UAS) - Lentiviral mouse Ccl17 shRNA (UAS, RFP) plasmid
Ask
View Details